March 24, 2018 4:01 PM ET


Company Overview of MBiotec GmbH

Company Overview

MBiotec GmbH develops novel compounds for the treatment of pancreatic cancer. It offers MALP-2S, a TLR2/6-agonist, which stimulates the innate and the specific immune system. The company is based in Seefeld, Germany.

Höhenweg 13

Seefeld,  82229



49 8152 99 89 805

Key Executives for MBiotec GmbH

MBiotec GmbH does not have any Key Executives recorded.

Similar Private Companies By Industry

Company Name Region
3B Pharmaceuticals GmbH Europe
Accelsiors Group International Europe
advanceCor GmbH Europe
Aenova Group GmbH Europe
Aenova Holding GmbH Europe

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
The Advertising Council, Inc. United States
Tax Management Inc United States
John F. Kennedy Center For The Performing Arts United States
NYC2012, Inc. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact MBiotec GmbH, please visit Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at